Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Cell Death and Differentiation|June 15, 2019
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cellsDejan Vidovic, Thomas T Huynh, Prathyusha Konda, et al.American Journal of Cancer Research|February 10, 2022
Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell deathPrathyusha Konda, John A Roque Iii, Liubov M Lifshits, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
RTN4 Knockdown Dysregulates the AKT Pathway, Destabilizes the Cytoskeleton, and Enhances Paclitaxel-Induced Cytotoxicity in CancersGopal P Pathak, Rashmi Shah, Barry E Kennedy, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
A framework for target discovery in rare cancersBingchen Li, Ananthan Sadagopan, Jiao Li, et al.Chemical Reviews|October 9, 2018
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433Susan Monro, Katsuya L Colón, Huimin Yin, et al.Experimental Neurology|August 4, 2020
Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitisScott P Holman, Aurelio S Lobo, Robyn J Novorolsky, et al.Cancer Research|May 16, 2019
Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic ReovirusBarry E Kennedy, John Patrick Murphy, Derek R Clements, et al.Journal of Proteome Research|March 1, 2017
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell ImmunotherapiesJ Patrick Murphy, Prathyusha Konda, Daniel J Kowalewski, et al.Journal of Proteome Research|May 17, 2019
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer ImmunotherapyJ Patrick Murphy, Youra Kim, Derek R Clements, et al.Chemical Science|May 12, 2021
Near-infrared absorbing Ru(ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanomaLiubov M Lifshits, John A Roque Iii, Prathyusha Konda, et al.Pageof 4